Cedar Brook Financial Partners, LLC Astrazeneca PLC Transaction History

Cedar Brook Financial Partners, LLC

  • $497 Million
  • Q1 2024

A detailed history of Cedar Brook Financial Partners, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Cedar Brook Financial Partners, LLC holds 12,416 shares of AZN stock, worth $957,646. This represents 0.17% of its overall portfolio holdings.

Number of Shares
12,416
Previous 12,472 0.45%
Holding current value
$957,646
Previous $839,000 0.24%
% of portfolio
0.17%
Previous 0.19%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 17, 2024
SELL
$61.03 - $69.57 $3,417 - $3,895
-56 Reduced 0.45%
12,416 $841,000
Q4 2023

Jan 12, 2024
SELL
$61.89 - $69.28 $38,928 - $43,577
-629 Reduced 4.8%
12,472 $839,000
Q3 2023

Oct 17, 2023
BUY
$64.85 - $71.7 $6,225 - $6,883
96 Added 0.74%
13,101 $887,000
Q2 2023

Jul 05, 2023
SELL
$69.91 - $75.81 $41,736 - $45,258
-597 Reduced 4.39%
13,005 $930,000
Q1 2023

Apr 04, 2023
BUY
$63.15 - $71.6 $22,291 - $25,274
353 Added 2.66%
13,602 $944,000
Q4 2022

Feb 01, 2023
BUY
$54.21 - $70.44 $68,196 - $88,613
1,258 Added 10.49%
13,249 $898,000
Q3 2022

Jan 03, 2023
BUY
$53.02 - $135.75 $54,663 - $139,958
1,031 Added 9.41%
11,991 $657,000
Q2 2022

Aug 12, 2022
SELL
$59.26 - $71.14 $33,304 - $39,980
-562 Reduced 4.88%
10,960 $724,000
Q1 2022

Apr 06, 2022
BUY
$55.72 - $67.12 $17,217 - $20,740
309 Added 2.76%
11,522 $764,000
Q4 2021

Jan 27, 2022
BUY
$54.02 - $63.83 $18,690 - $22,085
346 Added 3.18%
11,213 $653,000
Q3 2021

Nov 01, 2021
BUY
$55.56 - $60.79 $37,225 - $40,729
670 Added 6.57%
10,867 $653,000
Q2 2021

Aug 16, 2021
BUY
$48.42 - $60.18 $38,542 - $47,903
796 Added 8.47%
10,197 $611,000
Q1 2021

May 11, 2021
BUY
$47.16 - $54.44 $57,157 - $65,981
1,212 Added 14.8%
9,401 $467,000
Q4 2020

Feb 12, 2021
BUY
$48.52 - $58.02 $50,169 - $59,992
1,034 Added 14.45%
8,189 $409,000
Q3 2020

Nov 09, 2020
BUY
$53.07 - $61.1 $5,943 - $6,843
112 Added 1.59%
7,155 $392,000
Q2 2020

Aug 05, 2020
SELL
$43.1 - $55.31 $6,249 - $8,019
-145 Reduced 2.02%
7,043 $373,000
Q1 2020

May 07, 2020
SELL
$37.79 - $51.33 $16,476 - $22,379
-436 Reduced 5.72%
7,188 $321,000
Q4 2019

Feb 06, 2020
SELL
$42.46 - $50.46 $6,878 - $8,174
-162 Reduced 2.08%
7,624 $380,000
Q3 2019

Oct 24, 2019
BUY
$40.12 - $45.47 $34,904 - $39,558
870 Added 12.58%
7,786 $347,000
Q2 2019

Aug 06, 2019
BUY
$37.28 - $41.68 $9,618 - $10,753
258 Added 3.88%
6,916 $285,000
Q1 2019

May 08, 2019
BUY
$35.49 - $43.02 $236,292 - $286,427
6,658 New
6,658 $269,000

Others Institutions Holding AZN

# of Institutions
1,248
Shares Held
477M
Call Options Held
5.99M
Put Options Held
5.24M
View Full List

About ASTRAZENECA PLC

AZN Quotes by TradingView
  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $239B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Cedar Brook Financial Partners, LLC Portfolio

Follow Cedar Brook Financial Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cedar Brook Financial Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cedar Brook Financial Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email